Showing results (121-130 of 161) with videos related to

Sort By:
Pageof 17
Urologic Oncology|October 7, 2019
Comparison of standard vs. palliative management for bladder cancer in patients older than 85 years: multicenter study of 317 de novo tumorsAlbert Carrion, Jorge Huguet, Maria José Ribal, et al.
Cancers|April 12, 2022
Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate CancerJuan Morote, Angel Borque-Fernando, Marina Triquell, et al.
The Journal of Urology|December 27, 2014
The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapyJuan Morote, Antonio Gómez-Caamaño, José L Alvarez-Ossorio, et al.
European Urology Oncology|May 18, 2019
Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical TrialJ Alfred Witjes, Juan Morote, Erik B Cornel, et al.
The Prostate|April 8, 2015
Urinary biomarkers for the detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasiaTamara Sequeiros, Juan M Bastarós, Milagros Sánchez, et al.
Journal of Medical Education and Curricular Development|November 20, 2025
The Absence of International Standardized Quality Criteria in Doctorate Programs in Surgery: A Survey StudyNúria Llorach-Perucho, Manuel Pera, Eloy Espín-Bassany, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|August 6, 2024
Validation of the Barcelona-MRI predictive model when PI-RADS v2.1 is used with trans-perineal prostate biopsiesJuan Morote, Nahuel Paesano, Natàlia Picola, et al.
Biomolecules|February 24, 2024
Effect of 5-Alpha Reductase Inhibitors on Magnetic Resonance Imaging and Prostate Cancer DetectionJuan Morote, Natàlia Picola, Jesús Muñoz-Rodriguez, et al.
Urologic Oncology|November 8, 2020
Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findingsJuan Morote, Iván Schwartzman, Angel Borque, et al.
Oncotarget|February 22, 2018
Under-expression of CK2β subunit in ccRCC represents a complementary biomarker of p-STAT3 Ser727 that correlates with patient survivalJordi Vilardell, Estefania Alcaraz, Eduard Sarró, et al.
Pageof 17